173 related articles for article (PubMed ID: 9417758)
1. [Cyclophosphamide therapy in systemic lupus erythematosus].
Backhaus M; Hiepe F
Z Rheumatol; 1997; 56(4):178-89. PubMed ID: 9417758
[TBL] [Abstract][Full Text] [Related]
2. Clinical effects of intermittent, intravenous cyclophosphamide in severe systemic lupus erythematosus.
Martinelli R; Pereira LJ; Santos ES; Rocha H
Nephron; 1996; 74(2):313-7. PubMed ID: 8893147
[TBL] [Abstract][Full Text] [Related]
3. Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
Igarashi T; Igarashi T; Shimizu A; Itoh Y
J Nippon Med Sch; 2013; 80(5):396-400. PubMed ID: 24189359
[TBL] [Abstract][Full Text] [Related]
4. Intravenous cyclophosphamide in lupus nephritis.
Leondike MR; Shattuck MA
J Intraven Nurs; 1993; 16(1):23-7. PubMed ID: 8437043
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide in lupus nephritis.
Houssiau FA
Lupus; 2005; 14(1):53-8. PubMed ID: 15732289
[TBL] [Abstract][Full Text] [Related]
6. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
[TBL] [Abstract][Full Text] [Related]
7. [Invasive disseminated aspergillosis in combined immunosuppressive therapy in systemic lupus erythematosus].
Teuber G; Schwarting A; Mildenberger P; Schmidt-Brücken G; Moll R; Bornemann A; Wandel E; Wanitschke R; Meyer zum Büschenfelde KH
Med Klin (Munich); 1996 Dec; 91(12):798-801. PubMed ID: 9082168
[No Abstract] [Full Text] [Related]
8. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
Petri M; Jones RJ; Brodsky RA
Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
[TBL] [Abstract][Full Text] [Related]
10. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
Sixdorf U; Bauer H; Märker-Hermann E
Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
[TBL] [Abstract][Full Text] [Related]
12. [The efficacy of cyclophosphamide bolus therapy in a girl with SLE with a nephritic onset].
Ballati G; Tucciarone L; Diamanti A; Frangella E; Chiaramida N
Minerva Pediatr; 1991 Sep; 43(9):573-6. PubMed ID: 1758394
[TBL] [Abstract][Full Text] [Related]
13. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study.
Mehra S; Usdadiya JB; Jain VK; Misra DP; Negi VS
Rheumatol Int; 2018 Apr; 38(4):557-568. PubMed ID: 29450636
[TBL] [Abstract][Full Text] [Related]
14. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of two cyclophosphamide regimens for the treatment of lupus nephritis in Puerto Ricans: low vs. standard dose.
Castro-Santana LE; Colón M; Molina MJ; Rodríguez VE; Mayor AM; Vilá LM
Ethn Dis; 2010; 20(1 Suppl 1):S1-116-21. PubMed ID: 20521398
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
[TBL] [Abstract][Full Text] [Related]
17. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
[TBL] [Abstract][Full Text] [Related]
18. Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome).
Calguneri M; Ozbalkan Z; Ozturk MA; Apras S; Ertenli AI; Kiraz S
Clin Rheumatol; 2006 Nov; 25(6):782-8. PubMed ID: 16547692
[TBL] [Abstract][Full Text] [Related]
19. Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide.
Katsifis GE; Tzioufas AG
Lupus; 2004; 13(9):673-8. PubMed ID: 15485101
[TBL] [Abstract][Full Text] [Related]
20. Successful bosentan therapy in a case of pulmonary arterial hypertention developed during immunosuppressive therapy for lupus nephritis.
Ueda Y; Takahashi Y; Yamashita H; Kaneko H; Mimori A
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(2):99-104. PubMed ID: 21628852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
